Alnylam Pharmaceuticals (ALNY)
(Delayed Data from NSDQ)
$152.29 USD
-2.04 (-1.32%)
Updated May 8, 2024 04:00 PM ET
After-Market: $152.25 -0.04 (-0.03%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.78 | -1.10% |
Earnings Summary
For their last quarter, Alnylam Pharmaceuticals (ALNY) reported earnings of -$0.16 per share, beating the Zacks Consensus Estimate of $-0.75 per share. This reflects a positive earnings surprise of 78.67%. Look out for ALNY's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.78 per share, reflecting a year-over-year increase of 64.71%.
Earnings History
Price & Consensus
Zacks News for ALNY
Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics
ALNY: What are Zacks experts saying now?
Zacks Private Portfolio Services